THOMAS D. BROWN - Corporate Board Profile

Accelerate Diagnostics, Inc

Filing Date	Source Excerpt
2018-04-12	The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2017: Thomas D. Brown Option Award(1) ($) 161,802 Total ($) 161,802
2019-04-05	Directors who are also employees of the Company (including Mr. Mehren) do not receive any separate compensation in connection with their Board service, and we do not pay cash fees to any of our directors. Our non-employee directors generally receive a non-qualified initial stock option award upon joining the Board, which is calculated using a pre-determined formula and vests 20% per year over a five-year period, beginning on the first anniversary of the date of the director’s election to the Board. Non-employee directors also receive annual non-qualified stock option awards, in recent years under the 2012 Incentive Plan, which are calculated using a pre-determined formula and vest in 12 equal monthly installments, beginning one month after the date of grant. We reimburse directors for reasonable expenses related to their Board service.The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2018: Name Option Award(1) ($) Total ($) Thomas D. Brown (3) 115,667(2) 115,667 As of December 31, 2018, Mr. Brown held 56,359 options to purchase shares of our common stock. The members of the Compensation Committee during 2018 were Messrs. Brown, Strobeck, and Watts.
2020-04-01	Thomas D. Brown has served as a Director of the Company since March 14, 2017. ... The Board maintains a standing Compensation Committee comprised of Messrs. Brown (Chairman) and Patience, Ms. Francesconi and Dr. Watts. ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2019: Thomas D. Brown (5) Option Award (1) ($) 133,904 Total ($) 133,904
2021-04-05	The following table sets forth certain information with respect to the current directors, director nominees and executive officers of our Company: Thomas D. Brown 73 Director... The Board has affirmatively determined that directors Brown... are independent directors... The Board maintains a standing Compensation Committee comprised of Messrs. Brown (Chairman)... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2020: Thomas D. Brown 58,254 58,254
2022-04-07	Thomas D. Brown has served as a Director of the Company since March 14, 2017. Mr. Brown has more than 30 years’ experience in the clinical diagnostics industry. ... The Board has affirmatively determined that directors Brown ... are “independent directors” ... The Board maintains a standing Audit Committee comprised of Messrs. ten Brink (Chairman), Burris, Miller and Dr. Strobeck. ... The Board maintains a standing Compensation Committee comprised of Messrs. Brown (Chairman), Massarany, and Patience, Ms. Francesconi and Dr. Watts. ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2021: Thomas D. Brown 140,799
2023-05-01	Thomas D. Brown has served as a Director of the Company since March 14, 2017. Mr. Brown has more than 30 years’ experience in the clinical diagnostics industry... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2022: Thomas D. Brown 45,569